Africa ’s Investment Drive Gathers Pace

Africa Investment Forum 2018By Farhana Haque RahmanROME, Oct 18 2019 (IPS) Headwinds are blowing amid IMF warnings of a “synchronised slowdown” in global economic growth, yet Africa’s investment drive is still gathering pace, supported by intense international competition in development finance. Despite the global slowdown, 19 sub-Saharan countries are among nearly 40 emerging markets and developing economies forecast by the IMF to maintain GDP growth rates above 5 percent this year. Particularly encouraging for Africa is that its present growth leaders are richer in innovation than natural resources. While Akinwumi Adesina, president of the African Development Bank, admits to sleepless nights over the “headwinds” to African growth – primarily the US-China trade war – he remains excited over the continent’s prospects as the AfDB gears up for its annual Africa Investment Forum. The November 11-13 gathering in Johannesburg follows major milestones achieved in 2019, notably the coming into force of the African Continental Free Trade Agreement, described by Adesina as a “phenomenal development”. In May, 54 of Africa’s 55 countries became signatories to the initiative which aims to eliminate 90 percent of tariffs on goods and significantly reduce non-tariff barriers. The free trade area means to integrate Africa into a unified market with a population of over one billion and output of $1.3 trillion. The AfDB does n...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Africa Armed Conflicts Climate Change Combating Desertification and Drought Development & Aid Economy & Trade Featured Financial Crisis Green Economy Headlines Health Labour Peace TerraViva United Nations Trade & Investment Source Type: news

Related Links:

Source: Journal of American College Health - Category: Universities & Medical Training Authors: Source Type: research
Multiple myeloma (MM) patients (pts) are older and have poorer quality of life (QOL) compared to pts with other hematologic malignancies (Nielsen et al, Eur J Haematol 2017). Autologous hematopoietic stem cell transplantation (HCT) acutely exacerbates psychosocial distress&insomnia. These symptoms are often treated with benzodiazepines and zolpidem-class drugs (B/Z Rx) that come with serious toxicities in older adults. B/Z Rx patterns in HCT recipients, particularly among MM patients who tend to be older with more co-morbidities, are unknown.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Tags: 541 Source Type: research
ConclusionsQuality of life decreases during treatment, half a year after hospital stay there are still restrictions in some areas. A special focus should be given on head and neck cancer patient ’s quality of life in the aftercare.
Source: European Archives of Oto-Rhino-Laryngology - Category: ENT & OMF Source Type: research
Major Depression — the clinical type — is not a normal part of aging. Though it can appear at any age, older adults are at an increased risk. The Centers for Disease Control and Prevention (CDC) distinguishes this condition from having “the blues” and likens it to other medical illnesses that are treatable, like diabetes or hypertension. Overwhelming sadness and anxiety can last for weeks at a time or much longer, with a wide range of other discouraging symptoms. Yet, there are things that can help.  Statistics tell us that later in life, at least one chronic disease will affect 80 percent of u...
Source: World of Psychology - Category: Psychiatry & Psychology Authors: Tags: Aging Depression depression risk Elderly seniors Source Type: blogs
ConclusionThis is the first study to prospectively demonstrates that CBT-I is feasible in people with MS and produces promising improvements in insomnia severity, sleep quality, sleep self-efficacy and comorbid symptoms of fatigue, depression, and anxiety. Future studies are needed to determine mechanisms for these improvements and expand the scope of individuals with MS who may benefit from CBT-I. Furthermore, considering the moderate to large improvements experienced by the brief education group and the limited number of CBT-I providers, a stepped-care approach warrants consideration. Trial Registry:, ...
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
AbstractWe conducted a quasi-experimental study to test the effects of “the empowerment program for parents of adults with autism spectrum disorder” by Kawada and Nojima (J Kochi Women’s Univ Acad Nurs 44(1):43–55, 2018). The program has been developed on the theoretical premises of the family empowerment model and the andragogy model. The subjects were 36 pare nts of adults with high-functioning autistic spectrum disorder; 21 parents in the intervention group, and 15 parents in the control group. Outcome measures were the family empowerment scale (FES) modified by the author, the general health que...
Source: Journal of Psychosocial Rehabilitation and Mental Health - Category: Psychiatry Source Type: research
(Natural News) Many of us struggle with insomnia, and when you wake up after a night of tossing and turning, it can be hard to say for sure just how much time you actually slept. However, if you’re turning to sleep apps or smart watches to help you pin down just how much shut-eye you’re...
Source: - Category: Consumer Health News Source Type: news
In conclusion, these results indicated that SXD produced beneficial sedative and hypnotic bioactivities mediated by regulating the serotonergic and immune system.
Source: Metabolic Brain Disease - Category: Neurology Source Type: research
Conclusion: This study determined that there is a relationship between insomnia and depressive symptoms and that pregnant women experiencing insomnia presented with more depressive symptoms.Keywords: Depressions, last trimester, pregnancy, sleep characteristics.
Source: African Health Sciences - Category: African Health Source Type: research
A recent 3-month double-blind placebo-controlled study demonstrated efficacy and safety of child-appropriate prolonged-release melatonin (PedPRM) for insomnia in children with autism spectrum disorder (ASD). Here, we report on the long-term effects of PedPRM treatment on sleep, growth, body mass index, and pubertal development.
Source: Journal of the American Academy of Child and Adolescent Psychiatry - Category: Psychiatry Authors: Tags: New Research Source Type: research
More News: African Health | China Health | Contracts | Economic Slowdown | Economy | Eritrea Health | Ethiopia Health | Insomnia | International Medicine & Public Health | Mozambique Health | Nigeria Health | Pensions | Russia Health | United Nations | Warnings